SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Total Voting Rights

22 Feb 2012 14:10

RNS Number : 9202X
Accsys Technologies PLC
22 February 2012
 



AIM: AXS

NYSE Euronext Amsterdam: AXS

22 February 2012

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Total Voting Rights

 

Further to the recent announcement of the issue of ordinary shares in the Company pursuant to the Company's Employee Share Participation Plan, and pursuant to 5.6.1 of the Disclosure and Transparency Rules, the Company notifies the market of the following:

 

The issued share capital of the Company now consists of 404,016,642 ordinary shares of €0.01 each with voting rights. No ordinary shares are held in treasury.

 

The above figure of 404,016,642 ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules. This figure replaces and supersedes any figure previously announced.

 

ENDS

For further information, please contact:

Accsys Technologies PLC

Paul Clegg, CEO

Hans Pauli, CFO

 via Citigate Dewe Rogerson

 

Numis Securities

Nominated Adviser: Oliver Cardigan

Corporate Broking: Christopher Wilkinson

Ben Stoop

 

+44 (0)20 7260 1000

 

 

Citigate Dewe Rogerson

Ginny Pulbrook

Malcolm Robertson

Suzanne Bakker

 

+44 20 7282 2945

+44 20 7282 2867

+31 20 575 4023

 

 

Notes to Editors:

Accsys Technologies PLC(www.accsysplc.com ) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in Windsor, United Kingdom, and an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc). All group subsidiaries are ultimately 100% owned by Accsys and trade as Accsys Technologies. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam by NYSE Euronext, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) Accoya® wood production; (ii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

Accoya® wood (www.accoya.com ) is produced using Accsys' proprietary patented process, that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and temperate hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. For marine uses where weight is also important, Accoya® wood for the first time provides boat builders with a wood that is strong, lightweight, durable and retains its natural beauty for far longer. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

Tricoya® Wood Elements (www.tricoya.com ) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles and are used in the fabrication of wood based composites, including panel products. These composites demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

For an archive of news, visit www.accoya.com/news or www.accsysplc.com/news

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRPGUMUPUPPGCP
Date   Source Headline
4th Feb 20094:40 pmRNSSecond Price Monitoring Extn
4th Feb 20094:35 pmRNSPrice Monitoring Extension
26th Jan 20094:35 pmRNSPrice Monitoring Extension
21st Jan 20097:00 amRNSAccsys increases North American presence
13th Jan 20094:36 pmRNSPrice Monitoring Extension
24th Dec 200812:43 pmRNSSecond Price Monitoring Extn
24th Dec 200812:35 pmRNSPrice Monitoring Extension
22nd Dec 20084:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20084:38 pmRNSPrice Monitoring Extension
22nd Dec 20087:00 amRNSAccoya wood traffic bridge
18th Dec 20084:40 pmRNSSecond Price Monitoring Extn
18th Dec 20084:36 pmRNSPrice Monitoring Extension
9th Dec 20087:00 amRNSGrant of Share Options
8th Dec 20087:01 amRNSInterim Results
28th Nov 20084:40 pmRNSSecond Price Monitoring Extn
28th Nov 20084:35 pmRNSPrice Monitoring Extension
24th Nov 20084:55 pmRNSSecond Price Monitoring Extn
24th Nov 20084:37 pmRNSPrice Monitoring Extension
13th Nov 20087:00 amRNSAccsys Announces Partnership with Bella Vista
12th Nov 20087:00 amRNSAccsys expands into Africa
6th Nov 20087:00 amRNSAccsys expands into North America
27th Oct 20087:00 amRNSHolding(s) in Company
22nd Oct 20084:45 pmRNSSecond Price Monitoring Extn
22nd Oct 20084:37 pmRNSPrice Monitoring Extension
21st Oct 20084:43 pmRNSSecond Price Monitoring Extn
21st Oct 20084:35 pmRNSPrice Monitoring Extension
20th Oct 20084:41 pmRNSSecond Price Monitoring Extn
20th Oct 20084:36 pmRNSPrice Monitoring Extension
16th Oct 20084:46 pmRNSSecond Price Monitoring Extn
16th Oct 20084:41 pmRNSPrice Monitoring Extension
15th Oct 20084:43 pmRNSSecond Price Monitoring Extn
15th Oct 20084:36 pmRNSPrice Monitoring Extension
9th Oct 20087:00 amRNSAccoya to be used in M-Velope art structures
30th Sep 200810:24 amRNSAdditional Listing
25th Sep 20087:00 amRNSHolding(s) in Company
29th Aug 20087:00 amRNSTotal Voting Rights
15th Aug 20087:00 amRNSInterim Management Statement
14th Aug 20085:22 pmRNSResult of AGM
12th Aug 20087:00 amRNSAccsys Technologies Expands C
22nd Jul 20087:00 amRNSAccsys Named in World's Top 2
17th Jul 20087:00 amRNSAnnual Information Update
16th Jul 20085:19 pmRNSNotice of AGM
10th Jul 20084:41 pmRNSSecond Price Monitoring Extn
10th Jul 20084:36 pmRNSPrice Monitoring Extension
10th Jul 20087:00 amRNSAccsys joins Cleantech Index
24th Jun 20087:00 amRNSDividend Declaration
19th Jun 20087:55 amRNSDirectorate Change
19th Jun 20087:00 amRNSFinal Results
12th May 20081:45 pmRNSBoard Change & Directors' Dea
1st Apr 20087:00 amRNSInnovation & Eco Awards Won

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.